2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Carcinoma, Thymic: new trials by email Literature Review of Carcinoma, Thymic trials Research Report on Carcinoma, Thymic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma Atezolizumab - Carcinoma, Thymic | Phase 2 | Completed | Hoffmann-La Roche | 34 | 2020-08-07 | 2024-06-11 |
| Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies AZD6244, MK-2206, Lapatinib - Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell Lung | Phase 2 | Completed | National Cancer Institute (NCI) | 647 | 2011-02-08 | 2024-10-01 |
Thymoma (2) · Carcinoma, Non-Small-Cell Lung (1) · Small Cell Lung Carcinoma (1)
Hemic and Lymphatic Diseases (2) · Lymphatic Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Complex and Mixed (2) · Thoracic Neoplasms (2) · Thymus Neoplasms (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Lung Neoplasms (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1)
AZD 6244 (1) · Erlotinib Hydrochloride (1) · Lapatinib (1) · MK 2206 (1) · Sunitinib (1) · atezolizumab (1)
Hoffmann-La Roche (1) · National Cancer Institute (NCI) (1)
China (1) · United States (1)
Arun Rajan, M.D. (1)